We are international

Investigating the role of NAD+ and NAD+-dependent enzymes in Multiple Myeloma
Antonia Cagnetta, MD
Medical Oncology, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts, USA

Funded by the Annual "JC" Golf Tournament

NAD+ is an essential cofactor for several cellular functions. In mammals, NAD+ can be synthesized from Nicotinamide, nicotinic acid or tryptophan, by nicotinamide phosphoribosyltransferase (Nampt). Nampt occupies a pivotal role in controlling the activity of several cellular enzymes. Importantly it is upreguated in solid tumors and hematologic malignancies, however roles of this enzyme in cancer are to date poorly understood. Published data have shown that the intracellular depletion of NAD+ has antitumor effect and the chemical NAMPT inhibitor FK866 is reported to induce tumor cell death.

Based on the reported effects of FK866, I will investigate the effect and the mechanism of action of this novel compound against Multiple Myeloma cells, in order to provide the basis for an innovative approach to this hematological malignance.

 related articles